TGM2 and acute promyelocytic leukemia: In the context of canonical APL treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), TG2 expression is increased, and this leads to an intensification of inflammation through the NF-κB pathway [94].